With pandemic fatigue, and deaths and hospitalizations well down from peaks in 2021 because of high vaccination and immunity rates, many people are inclined to shrug off the new wave.
An HHS official said the department is in the process of identifying the COVID-19 vaccines that will move into the Phase IIb clinical trials.
Antibodies to COVID-19 were present in the blood of 96.4% of Americans over the age of 16 by September 2022. That’s according to an analysis testing for the presence of these immune defense molecules.
More Covid-19 articles